A Schiavone1, E Giraldo, L Giudici
1Department of Pharmacology, Boehringer Ingelheim Italia, (Istituto De Angeli s.p.A.), Milano.
DAU 6285, a novel compound, acts as a potent and selective antagonist for 5-hydroxytryptamine4 (5-HT4) receptors. This azabicycloalkyl benzimidazolone derivative shows higher affinity than ICS 205-930 and lacks significant interaction with other receptors.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: